Isosulfan blue

异硫蓝

Report date: 2024/06/14 20:00:57
NME

Base Information

Drug NameIsosulfan blue
Drug Alias Name异舒泛蓝异硫蓝Lymphazurin
ClassificationSmall moleculesDiagnostic agent (In vivo)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiagnostic agentsLymphedemaVulvar Neoplasms +[5] 
Global Approved IndicationsDiagnostic agentsLymphedema
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1981/07/29
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesCovidien
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer Institute
Inactive CompaniesCovidien
Active IndicationsBreast Neoplasms
Inactive IndicationsDiagnostic agentsLymphedemaVulvar Neoplasms +[4] 

Other Information

ATC CodeV04CX
Related LinksDrugBankKEGG